{"id":63659,"date":"2026-02-04T14:48:09","date_gmt":"2026-02-04T14:48:09","guid":{"rendered":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/"},"modified":"2026-02-04T14:48:09","modified_gmt":"2026-02-04T14:48:09","slug":"novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s","status":"publish","type":"post","link":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/","title":{"rendered":"Novo Nordisk debuts Wegovy weight-loss pill in the U.S."},"content":{"rendered":"<p> <script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-6606220950177433\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- ItShrt World News -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-6606220950177433\"\r\n     data-ad-slot=\"1882483372\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script>\r\n<br \/>\n<\/p>\n<div id=\"article-0\">\n  <!-- lil observer --><br \/>\n      <span class=\"content__observer-marker content__observer-marker--fixed lazyload\"\/><\/p>\n<section class=\"content__body\">\n<p>A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity.<\/p>\n<p>The starting dose of the daily Wegovy pill, at 1.5 milligrams, is now available for $149 per month for self-paying patients,<strong>\u00a0<\/strong>Novo Nordisk <a href=\"https:\/\/www.novonordisk-us.com\/media\/news-archive\/news-details.html?id=916476&amp;utm_medium=organic&amp;utm_source=twitter&amp;utm_campaign=2026-media-release&amp;utm_content=nni-weight-loss-pill-launch-sci_inn\" target=\"_blank\" rel=\"nofollow noopener\">announced<\/a> on Monday. A 4 mg dose of the medication is available for the same price through April 15, after which the cost will rise to $199.<\/p>\n<p>Ed Cinca, senior vice president of marketing and patient solutions at Novo Nordisk, said in a statement that the new drug represents a &#8220;significant innovation,&#8221; describing it as the &#8220;first and only&#8221; GLP-1 pill for weight loss.\u00a0<\/p>\n<p>The Food and Drug Administration (FDA) <span class=\"link\"><a href=\"https:\/\/www.cbsnews.com\/news\/fda-approves-wegovy-pill-weight-loss\/\" target=\"_blank\" data-invalid-url-rewritten-http=\"\">approved the pill version<\/a><\/span>\u00a0of Wegovy in December. Competitor Eli Lilly&#8217;s obesity pill,\u00a0<span class=\"link\"><a href=\"https:\/\/www.cbsnews.com\/news\/eli-lilly-glp-1-pill-trial-fda-approval\/\" target=\"_blank\" data-invalid-url-rewritten-http=\"\">orforglipron<\/a><\/span>, is still being reviewed by the FDA.<\/p>\n<p>The Novo Nordisk pill contains 25 milligrams of semaglutide, the same ingredient in injectables Wegovy and Ozempic. It also has similar side effects as the injectable version of the medication, including nausea and diarrhea, according to Novo Nordisk.\u00a0<\/p>\n<p>The new Wegovy pill provides Americans an alternative, and more convenient, option than injectable treatments, which have dominated the weight-loss market since they were introduced. Roughly 1 in 8 Americans has used an injectable GLP-1 drug for weight loss or another condition, according to a recent\u00a0<a href=\"https:\/\/www.kff.org\/public-opinion\/poll-1-in-8-adults-say-they-are-currently-taking-a-glp-1-drug-for-weight-loss-diabetes-or-another-condition-even-as-half-say-the-drugs-are-difficult-to-afford\/\" target=\"_blank\" rel=\"nofollow noopener\">survey<\/a>\u00a0from nonprofit group KFF.\u00a0<\/p>\n<p>Like the injectable version of Wegovy, the pill is intended to help patients shed body weight when coupled with diet and exercise. Novo Nordisk <a href=\"https:\/\/www.novonordisk-us.com\/media\/news-archive\/news-details.html?id=916476&amp;utm_medium=organic&amp;utm_source=twitter&amp;utm_campaign=2026-media-release&amp;utm_content=nni-weight-loss-pill-launch-sci_inn\" target=\"_blank\" rel=\"nofollow noopener\">said<\/a> that people who used the oral medication during phase 3 of clinical trials lost about 14% of their body weight, while those who stayed on the treatment lost about 17%.<\/p>\n<section class=\"content__body--footer\">\n<p class=\"content__meta--editors\">\n      Edited by<\/p>\n<p>                                  <a href=\"https:\/\/www.cbsnews.com\/team\/alain-sherter\/\" class=\"byline__author__link\" data-invalid-url-rewritten-http=\"\">Alain  Sherter<\/a>\n                      <\/p>\n<p class=\"content__meta--contributors\">\n<p>                      <span class=\"byline__author__text\">The Associated  Press<\/span><\/p>\n<p>        contributed to this report.\n    <\/p>\n<\/section>\n<p>  <!-- data-recirc-source=\"queryly\" --><\/p>\n<aside class=\"component list recirculation component--type-recirculation \">\n<p><h3 class=\"component__title\">More from CBS News<\/h3>\n<\/p>\n<div class=\"component__item-recirc-block\">\n<p><h3 class=\"component__title\">Go deeper with The Free Press<\/h3>\n<\/p><\/div>\n<\/aside>\n<section class=\"content__body--footer\">\n      <!-- tags --><\/p>\n<section class=\"content__tags\">\n<p class=\"content__tags__label\">In:<\/p>\n<\/section>\n<\/section>\n<\/section>\n<\/div>\n<p><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-6606220950177433\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- ItShrt World News -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-6606220950177433\"\r\n     data-ad-slot=\"1882483372\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script>\r\n<br \/>\n<br \/><a href=\"https:\/\/www.cbsnews.com\/news\/wegovy-weight-loss-pill-us-novo-nordisk\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving<\/p>\n","protected":false},"author":1,"featured_media":63660,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[7156,2899,2901],"class_list":["post-63659","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-2","tag-novo-nordisk","tag-wegovy","tag-weight-loss"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Novo Nordisk debuts Wegovy weight-loss pill in the U.S. - World News<\/title>\n<meta name=\"description\" content=\"FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo Nordisk debuts Wegovy weight-loss pill in the U.S. - World News\" \/>\n<meta property=\"og:description\" content=\"FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/\" \/>\n<meta property=\"og:site_name\" content=\"World News\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-04T14:48:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg\" \/><meta property=\"og:image\" content=\"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"998\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/\"},\"author\":{\"name\":\"News\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/person\/1d8ae7348e048cb7984f26b4dd818ff2\"},\"headline\":\"Novo Nordisk debuts Wegovy weight-loss pill in the U.S.\",\"datePublished\":\"2026-02-04T14:48:09+00:00\",\"dateModified\":\"2026-02-04T14:48:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/\"},\"wordCount\":313,\"publisher\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#organization\"},\"image\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1200&resize=1200,630&ssl=1\",\"keywords\":[\"Novo Nordisk\",\"Wegovy\",\"Weight Loss\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/\",\"url\":\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/\",\"name\":\"Novo Nordisk debuts Wegovy weight-loss pill in the U.S. - World News\",\"isPartOf\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1200&resize=1200,630&ssl=1\",\"datePublished\":\"2026-02-04T14:48:09+00:00\",\"dateModified\":\"2026-02-04T14:48:09+00:00\",\"description\":\"FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.\",\"breadcrumb\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#primaryimage\",\"url\":\"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1200&resize=1200,630&ssl=1\",\"contentUrl\":\"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1200&resize=1200,630&ssl=1\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/site.itshrt.com\/worldnews\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo Nordisk debuts Wegovy weight-loss pill in the U.S.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#website\",\"url\":\"https:\/\/site.itshrt.com\/worldnews\/\",\"name\":\"World News\",\"description\":\"World News\",\"publisher\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/site.itshrt.com\/worldnews\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#organization\",\"name\":\"World News\",\"url\":\"https:\/\/site.itshrt.com\/worldnews\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/site.itshrt.com\/worldnews\/wp-content\/uploads\/sites\/13\/2025\/01\/cropped-download.png\",\"contentUrl\":\"https:\/\/site.itshrt.com\/worldnews\/wp-content\/uploads\/sites\/13\/2025\/01\/cropped-download.png\",\"width\":581,\"height\":581,\"caption\":\"World News\"},\"image\":{\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/person\/1d8ae7348e048cb7984f26b4dd818ff2\",\"name\":\"News\",\"url\":\"https:\/\/site.itshrt.com\/worldnews\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novo Nordisk debuts Wegovy weight-loss pill in the U.S. - World News","description":"FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/","og_locale":"en_US","og_type":"article","og_title":"Novo Nordisk debuts Wegovy weight-loss pill in the U.S. - World News","og_description":"FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.","og_url":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/","og_site_name":"World News","article_published_time":"2026-02-04T14:48:09+00:00","og_image":[{"url":"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg","type":"","width":"","height":""},{"url":"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg","width":1920,"height":998,"type":"image\/jpeg"}],"author":"News","twitter_card":"summary_large_image","twitter_image":"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg","twitter_misc":{"Written by":"News","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#article","isPartOf":{"@id":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/"},"author":{"name":"News","@id":"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/person\/1d8ae7348e048cb7984f26b4dd818ff2"},"headline":"Novo Nordisk debuts Wegovy weight-loss pill in the U.S.","datePublished":"2026-02-04T14:48:09+00:00","dateModified":"2026-02-04T14:48:09+00:00","mainEntityOfPage":{"@id":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/"},"wordCount":313,"publisher":{"@id":"https:\/\/site.itshrt.com\/worldnews\/#organization"},"image":{"@id":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#primaryimage"},"thumbnailUrl":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1200&resize=1200,630&ssl=1","keywords":["Novo Nordisk","Wegovy","Weight Loss"],"articleSection":["Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/","url":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/","name":"Novo Nordisk debuts Wegovy weight-loss pill in the U.S. - World News","isPartOf":{"@id":"https:\/\/site.itshrt.com\/worldnews\/#website"},"primaryImageOfPage":{"@id":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#primaryimage"},"image":{"@id":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#primaryimage"},"thumbnailUrl":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1200&resize=1200,630&ssl=1","datePublished":"2026-02-04T14:48:09+00:00","dateModified":"2026-02-04T14:48:09+00:00","description":"FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.","breadcrumb":{"@id":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#primaryimage","url":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1200&resize=1200,630&ssl=1","contentUrl":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1200&resize=1200,630&ssl=1","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/site.itshrt.com\/worldnews\/novo-nordisk-debuts-wegovy-weight-loss-pill-in-the-u-s\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/site.itshrt.com\/worldnews\/"},{"@type":"ListItem","position":2,"name":"Novo Nordisk debuts Wegovy weight-loss pill in the U.S."}]},{"@type":"WebSite","@id":"https:\/\/site.itshrt.com\/worldnews\/#website","url":"https:\/\/site.itshrt.com\/worldnews\/","name":"World News","description":"World News","publisher":{"@id":"https:\/\/site.itshrt.com\/worldnews\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/site.itshrt.com\/worldnews\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/site.itshrt.com\/worldnews\/#organization","name":"World News","url":"https:\/\/site.itshrt.com\/worldnews\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/logo\/image\/","url":"https:\/\/site.itshrt.com\/worldnews\/wp-content\/uploads\/sites\/13\/2025\/01\/cropped-download.png","contentUrl":"https:\/\/site.itshrt.com\/worldnews\/wp-content\/uploads\/sites\/13\/2025\/01\/cropped-download.png","width":581,"height":581,"caption":"World News"},"image":{"@id":"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/site.itshrt.com\/worldnews\/#\/schema\/person\/1d8ae7348e048cb7984f26b4dd818ff2","name":"News","url":"https:\/\/site.itshrt.com\/worldnews\/author\/admin\/"}]}},"magazineBlocksPostFeaturedMedia":{"thumbnail":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=150&resize=150,150&ssl=1","medium":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=300&resize=300,300&ssl=1","medium_large":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=768&resize=768,0&ssl=1","large":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1024&resize=1024,1024&ssl=1","1536x1536":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1536&resize=1536,1536&ssl=1","2048x2048":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=2048&resize=2048,2048&ssl=1","colormag-highlighted-post":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=392&resize=392,272&ssl=1","colormag-featured-post-medium":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=390&resize=390,205&ssl=1","colormag-featured-post-small":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=130&resize=130,90&ssl=1","colormag-featured-image":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=800&resize=800,445&ssl=1","colormag-default-news":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=150&resize=150,150&ssl=1","colormag-featured-image-large":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1400&resize=1400,600&ssl=1","colormag-elementor-block-extra-large-thumbnail":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1155&resize=1155,480&ssl=1","colormag-elementor-grid-large-thumbnail":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=600&resize=600,417&ssl=1","colormag-elementor-grid-small-thumbnail":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=285&resize=285,450&ssl=1","colormag-elementor-grid-medium-large-thumbnail":"https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=575&resize=575,198&ssl=1"},"magazineBlocksPostAuthor":{"name":"News","avatar":"https:\/\/secure.gravatar.com\/avatar\/e85cf08852547781a5f631f3713dbb5197ed4b54e32ae19c7d5769b8c8504897?s=96&d=mm&r=g"},"magazineBlocksPostCommentsNumber":false,"magazineBlocksPostExcerpt":"A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving","magazineBlocksPostCategories":["Health"],"magazineBlocksPostViewCount":20,"magazineBlocksPostReadTime":2,"magazine_blocks_featured_image_url":{"full":["https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=1200&resize=1200,630&ssl=1",1200,630,false],"medium":["https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=300&resize=300,300&ssl=1",300,300,false],"thumbnail":["https:\/\/i1.wp.com\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/01\/05\/a6d4735f-f720-4ef7-9f21-bd7715d6d0a1\/thumbnail\/1200x630\/ed78ac3814701ea9c7026723efb2f537\/gettyimages-2158305291-1.jpg?w=150&resize=150,150&ssl=1",150,150,false]},"magazine_blocks_author":{"display_name":"News","author_link":"https:\/\/site.itshrt.com\/worldnews\/author\/admin\/"},"magazine_blocks_comment":0,"magazine_blocks_author_image":"https:\/\/secure.gravatar.com\/avatar\/e85cf08852547781a5f631f3713dbb5197ed4b54e32ae19c7d5769b8c8504897?s=96&d=mm&r=g","magazine_blocks_category":"<a href=\"#\" class=\"category-link category-link-36\">Health<\/a>","_links":{"self":[{"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/posts\/63659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/comments?post=63659"}],"version-history":[{"count":0,"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/posts\/63659\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/media\/63660"}],"wp:attachment":[{"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/media?parent=63659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/categories?post=63659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/site.itshrt.com\/worldnews\/wp-json\/wp\/v2\/tags?post=63659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}